Then we used different cutoff levels of AFP (400 ng/ml, 200 ng/ml and 100 ng/ml, respectively) to subgroup the 308 HCC patients and evaluated the prognostic significance of MACC1 in the patient subgroups. The gene discussed is AFP; the disease is hepatocellular carcinoma.